Особливості виникнення і прогнозування та підвищення ефективності лікування гастропатій, спричинених прийомом нестероїдних протизапальних препаратів, у хворих на остеоартроз

160. Genta R.M. Differential diagnosis of reactive gastropathy / R.M. Genta // Seminars in diagnostic pathology. - 2005. - Vol. 22 (4). - P. 273-283.

161. Genta R.M. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find / R.M. Genta, R.H. Lash // The American journal of surgical pathology. - 2010. - Vol. 34 (8). - P. 25-34.

162. Gosch M. Analgesics in geriatric patients: adverse side effects and interactions/ M. Gosch // Zeitschrift fur Gerontologie und Geriatrie. - 2015. - Vol. 48 (5). - P. 483-493.

163. Graham D.Y. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users / D.Y. Graham // Helicobacter. - 2002. - Vol. 7 (1). - P. 1-8.

164. Graham D.Y. Natural history of gastric cancer after Helicobacter eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally / D.Y. Graham, N. Uemura // Helicobacter. - 2006. - Vol. 11. - P. 139-143.

165. Guarner F. Probiotics in gastrointestinal diseases / F. Guarner // In: Versalovic J, Wilson M, editors. Therapeutic microbiology: probiotics and related strategies. - Washington, DC: ASM Press. - 2008. - P. 255-269.

166. Gupta S. Management of nonsteroidal, anti-inflammatory, drug-associated dyspepsia / S. Gupta, K. McQuaid // Gastroenterology. -- 2005. -- Vol. 129 (5). P. 1711-1719.

167. Helicobacter pylori and Nonsteroidal anti-inflammatory drugs: A Three-way Debate / Chan F.K., Hawkey CJ., Lanas A.I. // Amer. J. Med. - 2001. -Vol. 110 (1A). - P. 55-57.

168. Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms / Selgrad M., Bornschein J., Kandulski A. // International journal of cancer. Journal international du cancer. - 2014. - Vol. 135 (5). - P. 1127-1131.

169. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation / Suzuki M., Mimuro H., Kiga K. et al. // Cell. Host. Microbe. - 2009. - Vol. 5. - P. 23-34.

170. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells / Oldani A., Cormont M., Hofman V. et al. // PLoS Pathog. - 2009. - Vol. 5. - P. 1657-1671.

171. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index / Shiotani A., Miyanishi T., Uedo N., Iishi H. // Helicobacter. - 2005. - Vol. 10. - P. 373-378.

172. Helminth co-infection in Helicobacter pylori infected INS-GAS mice attenuates gastric premalignant lesions of epithelial dysplasia and glandular atrophy and preserves colonization resistance of the stomach to lower bowel microbiota / Whary M.T., Muthupalani S., Ge Z. et al. // Microbes and infection. - 2014. - Vol. 16 (4). - P. 345-355.

173. Higher leptin and adiponectin concentrations predict poorer performance-based physical functioning in midlife women: the michigan study of women's health across the nation / Karvonen-Gutierrez C.A., Zheng H., P. Mancuso P., Harlow S.D. // The journals of gerontology. Series A, biological aciences and medical sciences. - 2015. - Vol. 23 (1). - P. 345-352.

174. Hinojosa A. Correlacion de GR biliar con antecedente de colecistectomia y grupo control / Hinojosa A. - 2008. - Vol. 20 (4). - P. 277-284.

175. Hynes G.R. Leptin and its role in lipid metabolism / G.R. Hynes, P.J. Jones // Current Opinion in Lipidology. - 2001. - Vol. 12. - P. 321-327.

176. Iacobuzio A. Gastrointestinal and liver pathology / A. Iacobuzio, E.A. Montgomery // Philadelphia: Curchill Livingstone Elsevier, - 2005. - P. 69-71.

177. Impact of obesity on disability, function, and physical activity: data from osteoarthritis initiative / Batsis J.A., Zbehlik A.J., Barre L.K. et al. // Scandinavian journal of rheumatology. - 2015. - Vol. 63 (8). - P. 1552-1560.

178. Indomethacin-induced generation of reactive oxygen species leads to epithelial cell injury before the formation of intestinal lesions in mice / Tomita T., Sadakata H., Tamura M., Matsui H. // Journal of physiology and pharmacology. - 2014. - Vol. 65 (3). - P. 435-440.

179. Inflammaging and anti-inflammaging: systemic perspective on aging and longevity emerging from studies in humans / Franceschi C., Capri M., Monti D. et al. // Mech. Ageing Dev. - 2007. - Vol. 128. - P. 92-105.

180. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs / Fiorucci S., Antonelli E., Distrutti E. et al. // Gastroenterology. - 2005. - Vol. 129(4). - P. 1210-1224.

181. Influence of birth weight and gender on lipid status and adipose tissue gene expression in lambs / Wallace J.M., Milne J.S., Aitken R.P., Adam C.L. // Journal of molecular endocrinology. - 2014. - Vol. 53 (1). - P. 131-144.

182. Influence of vitamin C on mechanisms of cytoprotection, lipid peroxidation and NO-synthases under stress and experimental colitis in rats / Shamro N.R., Panasyuk N.B., Fomenko I.S., Sklyarov O.Ya. // Biology and medicine Issues Review. - 2011. - Vol. 3 (86). - P. 159-163.

183. Ileal inducible nitric oxide synthase mRNA expression in response to stress modified in Sprague-Dawley rats exposed to a previous intestinal inflammation / Jorge E., Vergata P., Martin M.T. // Stress. - 2012. - Vol. 15 (1). - P. 62-73.

184. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa / De Filippo C., Cavalieri D., Di Paola M. et al.] // Proceedings of the National Academy of Sciences of the United States of America. - 2010. - Vol. 107. - P. 14691-14696.

185. Is Helicobacter pylori seropositivity related to body mass index in the United States? / Ioannou G.N., Weiss N.S., Kearney D.J. // Alimentary pharmacological therapy. - 2005. - Vol. 21. - P.465-772.

186. Jiang S.M. Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats / S.M. Jiang, L. Jia, M.H. Zhang International journal of clinical and experimental medicine. - 2015. - Vol. 8 (6). - P. 9996-10000.

187. Kayacetin S. What is gastritis? What is gastropathy? How is it classified? / S. Kayacetin, S. Guresci // Turkish journal of gastroenterology. - 2014. - Vol. 25. P. 233-247.

188. Kumamato C. A. Inflammation and gastrointestinal Candida colonization / C. A. Kumamato // Curr. Opin. Microbiol. - 2011. - Vol. 14, № 4. - P. 386-391.

189. Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors / L. Laine L. // Seminars in arthritis and rheumatism. - 2002. - Vol. 32 (3). - P. 25-32.

190. Lanas A. A review of the gastrointestinal safety data - a gastroenterologists's perspective / A. Lanas A. // Rheumatology. - 2010. - Vol. 49. P. 113-110.

191. Lazzaroni M. Nonsteroidal anti-inflammatory drug gastropathy and Helicobacter pylori: the search for an Improbable Consensus / M. Lazzaroni, G. Bianchi Porro //Amer. J. Med. - 2001. - Vol. 110 (1A). - P.50-54.

192. Le Blanc A.M. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications / A.M. Le Blanc, J.G. Le Blanc // World journal of gastroenterology. - 2014. - Vol. 20, № 44. - P. 16518-16528.

193. Lems W.F. Prevention of NSAID gastropathy: the difference between a coxibs and the addition of a PPI / W.F. Lems, E.J. Kulpers // Nederlands tijdschrift voor geneeskunde. - Vol. 154 (45). - P. - 2663-2668.

194. Leptin - a link between obesity and osteoarthritis. applications for prevention and treatment / Vuolteenaho K., Koskinen A., Moilanen E. // Basic and clinical pharmacology and toxicology. - 2014. - Vol. 114 (1). - P. 103-108.

195. Leptin and ghrelin in relation to Helicobacter pylori status in adult males / Roper J., Shue P.L., Mourad M.S. et al. // Journal of clinical endocrinology and metabolism. - 2008. - Vol. 93. - P. 2350-2357.

196. Leptin receptor action and mechanisms of leptin resistance / Munzberg H., Bjornholm M., Bates S., Myers M.G. // Cellular and Molecular Life Sciences. - 2005. - Vol. 62. - P. 642-652.

197. Leptin secretion and leptin receptor in the human stomach / Sobhani I., Bado A., Vissuzaine C. et al. // Gut. - 2000. - Vol. 47. - P. 178-183.

198. Lim Y.J. Recent advances in NSAIDs-induced enteropathy therapeutics: new options, new challenges / Y.J. Lim, H.J. Chun // Gastroenterology research and practice. - 2013. - Vol. 13. - P. 1-7.

199. Linking long-term dietary patterns with gut microbial enterotypes / Wu G.D., Chen J., Hoffmann C. [et al.] // Science. - 2011. - Vol. 334. - P. 105-108.

200. Lomax A.R. Prebiotics, immune function, infection and inflammation: a review of the evidence / A.R. Lomax, P.C. Calder // British journal of nutrition. - 2008. - P. 1-26.

201. Low prevalence of clopidogrel and acetylsalicylic acid resistance in patients with acute myocardial infarction and pantoprazole treatment in everyday practice / K. Brendel, Weigel G. et al. // Internal Journal of Cardiology. - 2013. - Vol. 20. - P. 589-590.

202. Lundberg J.О. Biology of nitrogen oxides in the gastrointestinal tract / J.O. Lundberg, E. Weitzberg // Gut. - 2013. - Vol. 62(4). - P. 616-626.

203. Malfertheiner P. Author's response Helicobacter pylori eradication and gastric cancer prevention // P. Malfertheiner // Gut. - 2013. - Vol. 62 (6). - P. 950-951.

204. Management of Helicobacter pylori infection - the Maastricht IV / Florence Consensus Report / Malfertheiner P., Megraud F., O'Morain C. et al. // Gut. - 2012. - Vol. 61. - P. 646-664.

205. Martinez-Quintana E. Clopidogrel: A multifaceted affair / E. Martinez-Quintana, A. Tugores // Journal of clinical pharmacology. - 2015. - Vol. 55 (1). - P. 1-9.

206. Masaoka T. Safety of the long-term use of proton pump inhibitors / Masaoka T., Suzuki H., Hibi T. // Journal of clinical biochemistry and nutrition. - 2008. - Vol. 42 (3). - P. 191-196.

207. Mc Carberg B.H. Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safety / B.H. Mc Carberg, B. Cryer // American journal of therapeutics. - 2014. - Vol. 13. - P. 825-836.

208. Melanoma diagnosed 27 years after a benoxaprofen-induced photosensitivity reaction / Chin K.Y., El-Kayat B., Milme A., Hart A. - 2012. - Vol. 6 (1). - P. 5-7.

209. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors / Mollace V., Muscoli C. Masini E. et al. // Pharmacology research and perspectives. - 2005. - Vol. 57 (2). - P. 217-252.

210. Mechanisms behind gender differences in circulating leptin levels / Hellstroem L., Wahrenberg H., Hruska K. et al. // Journal of Internal Medicine. - 2000. - Vol. 247. - P. 457-462.

211. Meta-analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials / Yuan Y.H., Wang C., Yuan Y., Hunt R.H. // Alimentary pharmacology and therapeutics. - 2009. - Vol. 30 (3). - P. 197-209.

212. Metabolic stress-induced joint inflammation and osteoarthritis / Courties A., Gualillo O., Berenbaum F., Sellam J. // Osteoarthritis cartilage. - 2015. - Vol. 23 (11). - P. 1955-1965.

213. Microbiological effects of consuming a symbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria / Bartosch S., Woodmansey E.J., Paterson J.C.M. et al. // Clinical infectious diseases. - 2005. - Vol. 40. - P. 28-37.

214. Mitsuoko T. Bifidobacteria and their role in human health / T. Mitsuoko T. // J Ind Microbiol. - 1990. - Vol. 6. - P. 263-267.

215. Mode of delivery affects the bacterial community in the newborn gut / Biasucci G., Rubini M., Riboni S. // Early Hum Dev. - 2010. - Vol. 86, Suppl 1. - P. 13-15.

216. Mohamed J.A. A single nucleotide polymorphism in osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherihia coli is associated with an increased risk of non-secretory bacterial diarrhea in US travelers to Mexico / J.A. Mohamed // J Infect Dis. - 2009. - Vol. 199, № 4. - Р. 477-485.

217. Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy / Timmerman H.M., Konig C.J., Mulder L. [et al.] // International journal of food microbiology - 2004. - Vol. 96 (3). - P. 219-228.

218. Monteleone G. Targets for new immunomodulation strategies in inflammatory bowel disease / G. Monteleone, R. Caruso, F. Pallone // Autoimmunity reviews. - 2014. - Vol. 13 (1). - P. 11-14.

219. Mood disorders: a potential link between ghrelin and leptin on human body? Zarouna S., Wozniak G., Papachristou A. // World journal of experimental medicine. - 2015. - Vol. 5 (2). - P. 103-109.

220. Mucin expression in reactive gastropathy: an immunohistochemical analysis Mino-Kenudson M., Tomita S., Lauwers G.Y. // Arch. Pathol. Lab. Med. - 2007. - Vol. 131(1). - P. 86-90.

221. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats / Satoh H., Amagase K., Takeuchi K. // The journal of pharmacology and experimental therapeutics. - 2014. - Vol. 348 (2). - P. 227-235.

222. Narouze S. Obesity and chronic pain: opportunities for better patient care / S. Narouze, D. Souzdalnitski // Pain management. - 2015. - Vol. 5 (4). - P. 217-219.

223. Neef A. Future for probiotic science in functional food and dietary supplement development / A. Neef, Y. Sanz // Curr Opin Clin Nutr Metab Care. - 2013. - Vol. 16 (6). - Р. 679-687.

224. No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia / Lahner E., Sbrozzi-Vanni A., Vannella L. et al. // Digestive and liver disease. - 2012. - Vol. 44 (9). - P. 793-797.

225. Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease / Suissa D., Delaney J.A., Dial S., P. Brassard P. // British journal of clinical pharmacology. - 2012. - Vol. 74 (2). - P. 370-375.

226. New insight into the mechanisms of gastroduodenal injury induced by nonsteroidal anti-inflammatory drugs: practical implications / Kwiecien S., K. Magierowska K., Sliwowski Z. et al. // Polskie Archiwum Medycyny Wewnetrznej. - 2015. - Vol. 125 (3). - P. 191-198.

227. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent / Watanabe T., Higuchi K., Kobata A. et al. // Gut. - 2008. - Vol. 57 (2). - P. 181-187.

228. Obesity-related adipokines and shoulder osteoarthritis / Gandhi R., Takahashi M., Rizek R. et al. // The Journal of rheumatology. - 2012. - Vol. 39 (10). - P. 2046-2048.

229. O'Connor A. Digestive function of the stomach / A. O'Connor, C. O'Morain Digestive diseases. - 2014. - Vol. 32 (3). - P. 186-191.

230. Ogra P.L. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome / P.L. Ogra, R.C. Welliver // Nestle Nutr Workshop Ser Pediatr Program. - 2008. - Vol. 61. - P.145-181.

231. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group / Hawkey C.J., Karrasch J.A., Szczepanski L. et al. // The New England journal of medicine. - 1998. - Vol. 338 (11). - P. 727-734.

232. Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells / Le Beyec J., Pelletier A.L., Arapis K. et al. // International journal of obesity: journal of the International Association for the Study of obesity. - 2014. - Vol. 38 (10). - P. 1357-1364.

233. Patel R.M. Developmental biology of gut-probiotic interaction / R.M. Patel, P.W. Lin // Gut Microbes. - 2011. - Vol. 1 (3). - P. 186-195.

234. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial / Simpson M.R., Dotterud C.K., Storro O. [et al.] // BMC dermatology. - 2015. - Vol. 15 (1). - Р. 13.

235. Petsos G. Management of the human mucosal defensive barrier: evidence for glycan legislation / G. Petsos, A. Corfield // Biological chemistry. - 2009. - Vol. 390 (7). - P. 581-590.

236. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy / Wang Z.Y., Chen M., Zhu L.L. et al. // Therapeutics and clinical risk management. - 2015. - Vol. 11. - P. 449-467.

237. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defence and adaptation. Focus on nitric oxide and lipoxins / Brzozowski T., Konturek P.C., Pajdo R. et al. // J. Physiol. Pharmacol. - 2008. - Vol. 59 (2). - P. 89-102.

238. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study / Arbel Y., Finkelstein A., Halkin A. et al. // Clinical cardiology. - 2013. - Vol. 36 (6). - P. 342-346.

239. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications / Zhu L.L., Xu L.C., Chen Y. et al. // World journal of gastroenterology. - 2012. - Vol. 18 (24). - P. 3167-3172.

240. Potential role of NO in modulation of COX-2 expression and PGE2 production in pancreatic beta-cells / Ling J.J., Sun Y.I., Zhu D.Y. et al. // Acta biochimica et biophysica Sinica. - 2005. - Vol. 37 (2). - P. 139-146.

241. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients / Silva I., Teixeira A., Oliveira J. [et al.] // Clinical and experimental rheumatology. - 2015. - Vol. 33 (4). - P. 127-130.

242. Preidis G.A. Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era / G.A. Preidis, J. Versalovic // Gastroenterology. - 2009. - Vol. 136, № 6. - P. 2015-2031.

243. Prevention and treatment of NSAID gastropathy / Gargallo C.J., Sostres C., Lanas A. // Current Treatment Options in Gastroenterology. - 2014. - Vol. 12 (4). P. 398-413.

244. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study / Mego M., Chovanec J., Vochyanova-Andrezalova J. [et al.] // Complementary medical research. - 2015. - Vol. 23 (3). - P. 356-362.

245. Probiotics and prebiotics associated with aquaculture: a review / N. Akhter N., Wu B., A.M. Memon A.M., Mohsin M. // Fish and shellfish immunology. - 2015. - Vol. 45 (2). - P. 733-741.

246. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial / Kukkonen K., Savilahti E., Haahtela T. [et al.] // Journal of allergy and clinical immunology. 2007. - Vol. 119. - P. 192-198.

247. Probiotics as Complementary Treatment for Metabolic Disorders / Le Barz M., Anhe F., Varin T.V. [et al.] // Diabetes and metabolism journal. - 2015. - Vol. 39 (4). - P. 291-303.

248. Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis / Yu H.J., Liu W., Chang Z. et al. // World journal of gastroenterology. - 2015. Vol. 21. - P. 6561-6571.

249. Probiotics: immunomodulatory properties in allergy and eczema / Drago L., Toscano M., Pigatto P.D. // Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. - 2013. - Vol. 148. - P. 505-514.

250. Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats / Lam E.K., Yu L., Wong H.P. [et al.] // European journal of pharmacology. - 2007. - Vol. 565 (1-3). - P. 171-179.

251. Prophylactic probiotics for preventing necrotizing enterocolitis and reducing mortality in very low birth weight infants: a Meta-analysis / Wang X.L., Li X., Kang L., Wang S.H. // Chinese journal of contemporary pediatrics. - 2015. - Vol. 17 (8). - P. 852-858.

252. Protective role of leptin in acute gastric ulcers / Ptak-Belowska A., Brzozowski T., Pajdo R. et al. // Folia Med Cracov. - 2008. - Vol. 49 (3-4). - P. 23-35.

253. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis / Wallace J.L., S. Syer S., Denou E. [et al.] // Gastroenterology. 2011. - Vol. 141 (4). - P. 1314-1322.

254. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling / Johnson D.A., Chilton R. Liker H.R. // Postgraduate medicine.- 2014. - Vol. 126 (3). - P. 239-245.

255. PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions / Kupcinskas J., Wex T., Link A. [et al.] // Anticancer research. - 2014. - Vol. 34 (12). - P. 7167-7175.

256. Puenpatom R.A. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data / R.A. Puenpatom, T.W. Victor // Postgraduate medicine. - 2010. - Vol. 121 (6). - P. 9-20.

257. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study / Arbel Y., Birati E.Y., Finkelstein A. // Clinical cardiology. - 2013. - Vol. 36 (6). - P. 342-346.

258. Quick M. Cochrane Commentary: probiotics for prevention of acute upper respiratory infection / M. Quick. // Explore (NY). - 2015. - Vol. 11 (5). - P. 418-420.

259. Radioimmunoassay of leptin in human plasma / Ma Z., Gingerich R.L., Santiago J.V. et al. // Advances in clinical chemistry. - 1996. - Vol. 42. - P. 942-946.

260. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study / Tulassay Z., Szczepanski L. et al. // Helicobacter Eradication for Lesion Prevention. Lancet. - 1998. - Vol. 352. - P.1016-1021.

261. Rapid and accurate liquid chromatography and tandem mass spectrometry method for the simultaneous quantification of ten metabolic reactions catalyzed by hepatic cytochrome P450 enzymes / Shi R., Ma B., Wu J. [et al.] // Journal of separation science. - 2015. - Vol. 38 (19). - P. 3363-3373.

262. Reactive gastropathy is aasociated with inflammatory conditions throughout the gastrointestinal tract / Maguilnik I., Neumann W.L., Sonnenberg A., Genta R.M. // Alimentary Pharmacology and Therapeutics. - 2012. - Vol. 36. - P: 736-743.

263. Rebedea D. Medicamentous ulcer or medicamentous gastropathy / D. Rebedea // Med. Interna (Bucur). - 1969. - Vol. 21(7). - Р. 877-880.

264. Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID theraoy: 4 months follow-up study / Sokic-Milutinovic A., Krstic M., Rozer-Smolovic B. et al. // Digestive diseases and sciences. - 2010. - Vol. 55 (10). - P. 2887-2892.

265. Role of Helicobacter pylori infection on nutrition and metabolism / Francesco F., Tortora A., Di Rienzo T. et al. // World journal of gastroenterology. 2014. - Vol. 20 (36). - P. 12809-12815.

266. Role of leptin in resistance in the development of obesity in older patients / Carter S., Caron A., Richard D., Picard F. // Clinical interventions in aging. - 2013. - Vol. 8. - P. 829-844.

267. Role of nitric oxide-synthase and cyclooxygenase / lipooxygenase systems in development of experimental ulcerative colitis / Sklyarov A. Ya., Panasyuk N.B., Fomenko I.S. // Journal of Physiology and pharmacology. - 2011. - Vol. 62 (1). - P. 65-73.

268. Role of prostaglandins in gastroprotection and gastric adaptation / Brzozowski T., Konturek P.C., Konturek S.J. et al. // J. Physiol. Pharmacol. - 2005. - Vol. 56 (5). - P. 33-55.

269. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy / Gupta A., Dhiman R.K., Kumari S. et al. // Journal of hepatology. - 2010. - Vol. 53. - P. 849-855.

270. Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users / Muraki M., Fujiwara Y., Machida H. [et al.] // Scandinavian journal of gastroenterology. - 2014. - Vol. 49 (3). - P. 267-273.

271. Roth S.H. Coming to terms with nonsteroidal anti-inflammatory drug gastropathy / S.H. Roth // Drugs. - 2012. - Vol. 72 (7). - P. 873-879.

272. Roth S.H. From peptic ulcer disease to NSAID gastropathy. An envolving nosology / S.H. Roth // Drugs and aging. - 1995. - Vol. 6(5). - P. 358-367.

273. Roth S.H. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety / S.H. Roth // Clinical interventions in aging. - 2011. - Vol. 6. - P. 125-131.

274. Rubesin S.E. Gastritis from NSAIDs to Helicobacter pylori / S.E. Rubesin, E.E. Furth, M.S. Levine // Abdominal imaging. - 2005. - Vol. 30 (2). - P. 142-159.

275. Safety and efficacy of paracetamol and NSAIDs in osteoarthritis which drug to recommend? / Richette P., Latourte A., Frazier A. // Expert opinion on drug safety. - Vol. 14 (8). - P. 1259-1268.

276. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicenter trials / Baraf H.S., Gloth F.M., Barthel H.R. et al. // Drugs Aging. - 2011. - Vol. 28(1). - P. 27-40.

277. Safety of the long-term use of proton pump inhibitors / Thomson A.B., M.D. Sauve, Kassam N., Kamitakahara H. // World journal of gastroenterology. - 2010. Vol. 16 (19). - P. 2323-2330.

278. Sanchez J.C. Effects of adipokines and insulin on intracellular pH, calcium concentration, and responses to hypo-osmolarity in human articular chondrocytes from healthy and osteoarthritic cartilage / J.C. Sanchez, D.F. Lopez-Zapata // Cartilage. - 2015. - Vol. 6 (1). - P. 45-54.

279. Sandelli L.J. Obesity and osteoarthritis: is leptin the link? / Sandelli L.J. // American College of Rheumatology. - 2009. - Vol. 60 (10). - P. 2858-2860.

280. Sanders M.E. Impact of probiotics on colonizing microbiota of the gut / M.E. Sanders // Journal of clinical gastroenterology. - 2011. - Vol. 45. - P. 115-119.

281. Schellack N. An overview of gastropathy induced by nonsteroidal anti-inflammatory drugs / N. Schellack N. // S. Afr. Pharm. J. - 2012. - Vol. 79 (4). - P. 12-18.

282. Serum leptin concentration positively correlates with body weight and total fat mass in postmenopausal Japanese women with osteoarthritis of the knee / Iwamoto J., Takeda T., Sato Y., Matsumoto H. // Arthritis. - 2011. - P. 1-6.

283. Serum leptin level in patients with duodenal ulcer / Lankarani K.B., Moghadami M., Masoumpoor M. et al. // Iranian Journal of Basic Medical Sciences. - 2004. - Vol. 29(1). - P. 5-8.

284. Sex differences in serum leptin and its relation to markers of cardiometabolic risk in middle-aged adults: evidence from a population-based study / De Castro M.A., Baltar V.T., Marchioni D.M., Fisberg R.M. // Nutrition. - 2015. - Vol. 31 (3). - P. 491-497.

285. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity / Savcheniuk O., Kobyliak N., Kondro M. [et al.] // BMC complementary and alternative medicine. - 2014. - Vol. 14. - P. 247.

286. Sleator R.D. Designer probiotics: Development and applications in gastrointestinal health / R.D. Sleator // World journal of gastrointestinal pathophysiology. - 2015. - Vol. 6 (3). - P. 73-78.

287. Srivastova A. Pathology of non-infective gastritis / A. Srivastova, G.Y. Lauwers // Histopathology. - 2007. - Vol. 50. - P. 15-29.

288. Stanos S.P. Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs / S.P. Stanos // J. Multidiscip. Healthc. - 2013. - Vol. 6. - P. 133-137.

289. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity / A. Stofkova // Endocrine regulations. - 2009. Vol. 43. - P. 157-168.

290. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation / Ghelardi E., Celandroni F., Salvetti S. [et al.] // Journal of applied microbiology. - 2015. - Vol. 119 (2). - P. 552-559.

291. Syer S.D. Environmental and NSAID-enteropathy: dysbiosis as a common factor / S.D. Syer, J.L. Wallace // Current gastroenterology reports. - 2014. - Vol. 16 (3). - P. 377.

292. Symbiotic maple saps minimize disruption of the mice intestinal microbiota after oral antibiotic administration / Hammami R., Ben Abdallah N., Barbeau J., Fliss I. // International journal of food sciences. - 2015. - Vol. 28. - P. 1-7.

293. Tegmeyer N. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signaling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA / N. Tegmeyer // Cell. Microbiol. - 2009. - Vol. 11. - P. 488-505.

294. The association of gastric leptin with oesophageal inflammation and metaplasia / Francois F., Roper J., Goodman A.J. et al. // Gut. - 2008. - Vol. 57. - P. 16-24.

295. The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia Nasef S.A., Shaaban A.A., Mould-Quevedo J., Ismail T.A. // Health economics review. - 2015. - Vol. 5. - P. 13-21.

296. The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology / Tiihonen K., Tynkkynen S., Ouwehand A. et al. // British Journal of nutrition. - 2008. - Vol. 100. - P. 130-137.

297. The effects of leptin on gastric ulcer due to physical and psychological stress: involvement of nitric oxide and prostaglandine E2 / Fallahi S., Nabavizadeh F., Shahabadin Sadr S. et al. // Journal of stress physiology and biochemistry. - 2011. - Vol. 7 (4). - P. 301-310.

298. The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor / Sarapa N., Britto M.R., Mainka M.B., Parivar K. // European journal of clinical pharmacology. - 2005. - Vol. 61 (4). - P. 247-256.

299. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin / Watson S.A., Durrant L.G., Crosbie J.D. et al. // Korean journal of family medicine. - 2012. - Vol. 33 (5). - P. 692-696.

300. The incidence of Helicobacter pylori infection is not increased among young individuals in Greece / Kyriazanos I.D., Sfiniadakis I., Gizaris V. et al. // Journal of clinical gastroenterology. - 2002. - P. 541-546.

301. The intestinal microbiota influences campylobacter jejuni colonization and extraintestinal dissemination in mice / O'Loughlin J.L., Samuelson D.R., Braundmeier-Fleming A.G. [et al.] // Applied and environmental microbiology. - 2015. - Vol. 81 (14). - P. 4642-4650.

302. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? / Matarese G., Procaccini C., De Rosa V. // Journal of Leukocyte Biology. - 2008. - Vol. 84. - P. 893-899.

303. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure / Kennedy A., Gettys T.W., Watson P. et al. // The Journal of clinical endocrinology and metabolism. - 1997. - Vol. 82 (4). - P. 1293-1300.

304. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing / Dethlefsen L., Huse S., Sogin M.L. [et al.] // PLoS Biol. - 2008. - 6:e280.

305. The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials / Boers M., Tangelder M.J., van Ingen H., Goldstein J.L. // Annals of the rheumatic diseases. - 2007. - Vol. 66 (3). - P. 417-418.

306. The role of leptin in innate and adaptive immune responses / Bernotiene E., Palmer G., Gabay C. // Arthritis research and therapy. - 2006. - Vol. 8(5). - P. 1212-1222.

307. The Sydney system: a new classification of gastritis / Misiewicz J.J., Tytgat G.N.J., Goodwin C.S. et al. // 9th Congress of Gastroenterology. Working party reports. - Blackwell-Melburne, 1990. - P. 1-10.

308. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs / Helsper C.W., Smeets H.M., Numans M.E. et al. // Pharmacoepidemiology and drug safety. - 2009. - Vol. 18 (9). - P. 800-806.

309. Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes / Gargiulo G., Capodanno D., Longo G. et al. // Expert review of cardiovascular therapy. - 2014. - P. 1185-1203.

310. Use of Proton Pump Inhibitor and risk of colorectal cancer: a Meta-analysis of observational studies / Ahn J.S., Park S.H., Eom C.S. et al. // Korean journal of family medicine. - 2012. - Vol. 33 (5). - P. 272-279.

311. Vernygorodskyi S. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach / S. Vernygorodskyi // Exp. Oncol. - 2013. - Vol. 35(2). - P. 114-117.

312. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years / J. Wallace // Gastroenterology. - 1997. - Vol. 112. - P: 1000-1016.

313. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors / Y. Yamaoka // Nat. Rev. Gastroenterol. Hepatol. - 2010. - Vol. 14. - P. 154-167.

314. Yatsunenko T. Human gut microbiome viewed across age and geography / Yatsunenko T., Rey F.E., Gordon J.I. // Nature. - 2012. - Vol. 486 (7402). - Р. 222-227.

315. Zak M. The role of chronic gastritis in past medical history with NSAID administration in patients with osteoartrosis / M. Zak // Likars'ka sprava. - 2014. - Vol. 11. - P. 398-413.

316. Zhang W. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology / W. Zhang, M. Doherty // British journal of sports medicine. - 2006. - Vol. 40 (8). - P. 664-669.

317. Zhuang Y. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach / Y. Zhuang, D.E. de Vries, Z. Xu. [et al.] // Journal of clinical pharmacology. - 2015. - Vol. 55 (12). - P. 1386-1394.

Размещено на Allbest.ur

...